These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35897915)
1. Solanaceae Family Phytochemicals as Inhibitors of 3C-Like Protease of SARS-CoV-2: An In Silico Analysis. Mahmood RA; Hasan A; Rahmatullah M; Paul AK; Jahan R; Jannat K; Bondhon TA; Mahboob T; Nissapatorn V; de Lourdes Pereira M; Paul TK; Rumi OH; Wiart C; Wilairatana P Molecules; 2022 Jul; 27(15):. PubMed ID: 35897915 [TBL] [Abstract][Full Text] [Related]
2. In silico evaluation of Philippine Natural Products against SARS-CoV-2 Main Protease. Cheng AJT; Macalino SJY; Billones JB; Balolong MP; Murao LAE; Carrillo MCO J Mol Model; 2022 Oct; 28(11):345. PubMed ID: 36205801 [TBL] [Abstract][Full Text] [Related]
3. In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus. Eleftheriou P; Amanatidou D; Petrou A; Geronikaki A Molecules; 2020 May; 25(11):. PubMed ID: 32485894 [TBL] [Abstract][Full Text] [Related]
4. Biflavonoids from Lokhande K; Nawani N; K Venkateswara S; Pawar S J Biomol Struct Dyn; 2022 Jul; 40(10):4376-4388. PubMed ID: 33300454 [TBL] [Abstract][Full Text] [Related]
5. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. Kumar Y; Singh H; Patel CN J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274 [TBL] [Abstract][Full Text] [Related]
13. In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection. Martorana A; Gentile C; Lauria A Viruses; 2020 Jul; 12(8):. PubMed ID: 32722574 [TBL] [Abstract][Full Text] [Related]
14. In silico screening of Allium cepa phytochemicals for their binding abilities to SARS and SARS-CoV-2 3C-like protease and COVID-19 human receptor ACE-2. Bondhon TA; Fatima A; Jannat K; Hasan A; Jahan R; Nissapatorn V; Wiart C; Pereira ML; Rahmatullah M Trop Biomed; 2021 Jun; 38(2):214-221. PubMed ID: 34172713 [TBL] [Abstract][Full Text] [Related]
15. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM Life Sci; 2020 Aug; 255():117831. PubMed ID: 32450166 [TBL] [Abstract][Full Text] [Related]
16. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors. Ibrahim MAA; Abdelrahman AHM; Hussien TA; Badr EAA; Mohamed TA; El-Seedi HR; Pare PW; Efferth T; Hegazy MF Comput Biol Med; 2020 Nov; 126():104046. PubMed ID: 33065388 [TBL] [Abstract][Full Text] [Related]
17. Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2's main protease. Huynh T; Wang H; Luan B Phys Chem Chem Phys; 2020 Nov; 22(43):25335-25343. PubMed ID: 33140777 [TBL] [Abstract][Full Text] [Related]
18. Allosteric inhibitors of the main protease of SARS-CoV-2. Samrat SK; Xu J; Xie X; Gianti E; Chen H; Zou J; Pattis JG; Elokely K; Lee H; Li Z; Klein ML; Shi PY; Zhou J; Li H Antiviral Res; 2022 Sep; 205():105381. PubMed ID: 35835291 [TBL] [Abstract][Full Text] [Related]
19. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Kandeel M; Al-Nazawi M Life Sci; 2020 Jun; 251():117627. PubMed ID: 32251634 [TBL] [Abstract][Full Text] [Related]